Skip to main content

Advertisement

SpringerLink
Log in

Should patients with pathologic stage pT3 and pT4 RCC be reclassified to improve prognostic accuracy?

  • Practice Point
  • Published:

From Nature Clinical Practice Urology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kuczyk M et al. (2002) The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience. BJU Int 89: 517–522

    Article  CAS  Google Scholar 

  2. Alamdari FI and Ljungberg B (2005) Adrenal metastasis in renal cell carcinoma: a recommendation for adjustment of the TNM staging system. Scand J Urol Nephrol 39: 277–282

    Article  Google Scholar 

  3. Han KR et al. (2003) TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. J Urol 169: 899–903

    Article  Google Scholar 

  4. Kim HL et al. (2004) Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? J Urol 171: 588–591

    Article  Google Scholar 

  5. Ljungberg B et al. (1995) Vein invasion in renal cell carcinoma: impact on metastatic behavior and survival. J Urol 154: 1681–1684

    Article  CAS  Google Scholar 

  6. Ficarra V et al. (2001) Renal vein and vena cava involvement does not affect prognosis in patients with renal cell carcinoma. Oncology 61: 10–15

    Article  CAS  Google Scholar 

  7. Patard JJ et al. (2003) Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma. Eur Urol 44: 226–232

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Ford, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Urology, and the Chairman of the Department of Surgical and Perioperative Sciences, Umeå University, Umea, Sweden

    Börje Ljungberg

Authors
  1. Börje Ljungberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Börje Ljungberg.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Supplementary information

Supplementary Table 1

Proposed new TNM stage classifications in patients with pT3 and pT4 renal cell carcinoma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ljungberg, B. Should patients with pathologic stage pT3 and pT4 RCC be reclassified to improve prognostic accuracy?. Nat Rev Urol 3, 136–137 (2006). https://doi.org/10.1038/ncpuro0426

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0426

  • Springer Nature Limited

Search

Navigation